Ingredion is trading 5.16% down at $92.34 after its November 5, 2026, third-quarter report missed earnings expectations and management lowered its full-year outlook. - Adjusted EPS was $2.28, below the $2.55 consensus. - Challenges included Argo facility delays, input-cost inflation, softer consumer demand, and North American operating headwinds. - Results were scheduled for release before market open, making earnings and guidance a direct catalyst for the pre-market decline; no pre-market volume information was provided.